<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-03-11T00:46:48Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8603113" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8603113</identifier>
        <datestamp>2021-11-19</datestamp>
        <setSpec>pheelsevier</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3-mathml3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Chaos Solitons Fractals</journal-id>
              <journal-id journal-id-type="iso-abbrev">Chaos Solitons Fractals</journal-id>
              <journal-title-group>
                <journal-title>Chaos, Solitons, and Fractals</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0960-0779</issn>
              <issn pub-type="epub">0960-0779</issn>
              <publisher>
                <publisher-name>Elsevier Ltd.</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8603113</article-id>
              <article-id pub-id-type="pmcid">PMC8603113</article-id>
              <article-id pub-id-type="pmc-uid">8603113</article-id>
              <article-id pub-id-type="pmid">34815624</article-id>
              <article-id pub-id-type="pii">S0960-0779(21)00975-9</article-id>
              <article-id pub-id-type="doi">10.1016/j.chaos.2021.111621</article-id>
              <article-id pub-id-type="publisher-id">111621</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Modeling the effect of the vaccination campaign on the COVID-19 pandemic</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" id="au0001">
                  <name>
                    <surname>Angeli</surname>
                    <given-names>Mattia</given-names>
                  </name>
                  <xref rid="cor0001" ref-type="corresp">⁎</xref>
                  <xref rid="aff0001" ref-type="aff">a</xref>
                </contrib>
                <contrib contrib-type="author" id="au0002">
                  <name>
                    <surname>Neofotistos</surname>
                    <given-names>Georgios</given-names>
                  </name>
                  <xref rid="aff0001" ref-type="aff">a</xref>
                </contrib>
                <contrib contrib-type="author" id="au0003">
                  <name>
                    <surname>Mattheakis</surname>
                    <given-names>Marios</given-names>
                  </name>
                  <xref rid="aff0001" ref-type="aff">a</xref>
                </contrib>
                <contrib contrib-type="author" id="au0004">
                  <name>
                    <surname>Kaxiras</surname>
                    <given-names>Efthimios</given-names>
                  </name>
                  <xref rid="aff0001" ref-type="aff">a</xref>
                  <xref rid="aff0002" ref-type="aff">b</xref>
                </contrib>
                <aff id="aff0001"><label>a</label>John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA</aff>
                <aff id="aff0002"><label>b</label>Department of Physics, Harvard University, Cambridge, MA 02138, USA</aff>
              </contrib-group>
              <author-notes>
                <corresp id="cor0001"><label>⁎</label>Corresponding author.</corresp>
              </author-notes>
              <pub-date pub-type="pmc-release">
                <day>19</day>
                <month>11</month>
                <year>2021</year>
              </pub-date>
              <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
              <pub-date pub-type="ppub">
                <month>1</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>19</day>
                <month>11</month>
                <year>2021</year>
              </pub-date>
              <volume>154</volume>
              <fpage>111621</fpage>
              <lpage>111621</lpage>
              <history>
                <date date-type="received">
                  <day>27</day>
                  <month>8</month>
                  <year>2021</year>
                </date>
                <date date-type="rev-recd">
                  <day>25</day>
                  <month>10</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>5</day>
                  <month>11</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2021 Elsevier Ltd. All rights reserved.</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Elsevier Ltd</copyright-holder>
                <license>
                  <license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p>
                </license>
              </permissions>
              <abstract id="abs0001">
                <p>Population-wide vaccination is critical for containing the SARS-CoV-2 (COVID-19) pandemic when combined with restrictive and prevention measures. In this study we introduce SAIVR, a mathematical model able to forecast the COVID-19 epidemic evolution during the vaccination campaign. SAIVR extends the widely used Susceptible-Infectious-Removed (SIR) model by considering the Asymptomatic (A) and Vaccinated (V) compartments. The model contains several parameters and initial conditions that are estimated by employing a semi-supervised machine learning procedure. After training an unsupervised neural network to solve the SAIVR differential equations, a supervised framework then estimates the optimal conditions and parameters that best fit recent infectious curves of 27 countries. Instructed by these results, we performed an extensive study on the temporal evolution of the pandemic under varying values of roll-out daily rates, vaccine efficacy, and a broad range of societal vaccine hesitancy/denial levels. The concept of herd immunity is questioned by studying future scenarios which involve different vaccination efforts and more infectious COVID-19 variants.</p>
              </abstract>
              <kwd-group id="keys0001">
                <title>Keywords</title>
                <kwd>COVID-19</kwd>
                <kwd>Machine learning</kwd>
                <kwd>Neural networks</kwd>
                <kwd>Vaccines</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec id="sec0001">
              <label>1</label>
              <title>Introduction</title>
              <p id="p0006">The World Health Organization (WHO) declared the SARS-CoV-2 (COVID-19) outbreak in Wuhan to be a pandemic on March 11, 2020. Since then, COVID-19 has become a serious global health threat due to its rapid spread, transmission through asymptomatic infected individuals and complex epidemiological dynamics. As of May 2021, already more than 3 million lives have been lost due to the virus. The spread of SARS-CoV-2 has thus far been extremely difficult to contain.</p>
              <p id="p0007">By the end of 2020, the successful development of effective vaccines and the onset of their widespread distribution in most of the world’s countries, was hailed as the decisive mean to contain the pandemic. However, important questions linger on whether the vaccination effort will succeed in effectively eradicating the disease. The appearance and wide spread of more contagious SARS-Cov-2 strains, the onset and scale of the vaccine deployment and high levels of vaccine hesitancy/denial in the society, are among the key factors hindering the vaccination effort and the achievement of herd immunity. Modeling the impact of these key factors on the evolution of the pandemic is of critical importance for assessing the vaccination effectiveness against it.</p>
              <p id="p0008">In studying past epidemics, scientists have systematically applied “random mixing” compartmental models which assume that an infectious individual can spread the disease to any susceptible member of the population before becoming recovered or removed, as originally considered by Kermack and McKendrick <xref rid="bib0001" ref-type="bibr">[1]</xref>. These models constrain the total population in compartments by considering stages of the infection and flows among them.</p>
              <p id="p0009">In the present study we propose a new model named SAIVR, which incorporates two important characteristics of the COVID-19 epidemic, namely the considerable transmission of the disease by asymptomatic infected individuals and the vaccination campaign with World Health Organization (WHO) approved vaccines. More recent modeling approaches involve agent-based simulations <xref rid="bib0002" ref-type="bibr">[2]</xref>, heterogeneous social networks <xref rid="bib0003" ref-type="bibr">[3]</xref>, <xref rid="bib0004" ref-type="bibr">[4]</xref>, <xref rid="bib0005" ref-type="bibr">[5]</xref>, <xref rid="bib0006" ref-type="bibr">[6]</xref>, <xref rid="bib0007" ref-type="bibr">[7]</xref>, <xref rid="bib0008" ref-type="bibr">[8]</xref>, and Bayesian inference models <xref rid="bib0009" ref-type="bibr">[9]</xref>. Although a large number of research studies are currently investigating the COVID-19 epidemiological characteristics <xref rid="bib0010" ref-type="bibr">[10]</xref>, <xref rid="bib0011" ref-type="bibr">[11]</xref>, <xref rid="bib0012" ref-type="bibr">[12]</xref>, <xref rid="bib0013" ref-type="bibr">[13]</xref>, <xref rid="bib0014" ref-type="bibr">[14]</xref>, <xref rid="bib0015" ref-type="bibr">[15]</xref>, <xref rid="bib0016" ref-type="bibr">[16]</xref>, <xref rid="bib0017" ref-type="bibr">[17]</xref>, <xref rid="bib0018" ref-type="bibr">[18]</xref>, we believe that a simple but efficient model, which can capture the basics of the complex behavior of the pandemic including the vaccine roll-out, can offer useful guidance for the pandemic’s near-term and longer-term evolution. By using a recently developed semi-supervised machine learning approach <xref rid="bib0019" ref-type="bibr">[19]</xref>, <xref rid="bib0020" ref-type="bibr">[20]</xref>, <xref rid="bib0021" ref-type="bibr">[21]</xref> we systematically reproduced the pandemic dynamics during the 2021 spring in several different countries. We then used the model to assess the importance of a rapid vaccination campaign to prevent future outbreaks driven by more infectious variants.</p>
              <p id="p0010">The work is organized as follows. In <xref rid="sec0002" ref-type="sec">Section 2</xref> we introduce the SAIVR model and its parameters. The machine learning approach that we used to reproduce the infectious curves of 27 selected countries/states is thoroughly described in <xref rid="sec0003" ref-type="sec">Section 3</xref>. In <xref rid="sec0007" ref-type="sec">Section 4</xref> we study future scenarios involving more infectious variants making quantitative arguments on how they might affect herd immunity. <xref rid="sec0010" ref-type="sec">Section 5</xref> is devoted to concluding remarks.</p>
            </sec>
            <sec id="sec0002">
              <label>2</label>
              <title>The SAIVR model</title>
              <p id="p0011">One of the first attempts to mathematically describe the spread of an infectious disease is due to Kermack and McKendrick <xref rid="bib0001" ref-type="bibr">[1]</xref>. In 1927 they introduced the so-called Susceptible-Infectious-Removed (SIR) model. The SIR model describes the dynamics of a (fixed) population of <inline-formula><mml:math id="M1" altimg="si43.svg"><mml:mi>N</mml:mi></mml:math></inline-formula> individuals split into three compartments:<list list-type="simple" id="lst0004"><list-item id="lstitem0006"><label>•</label><p id="p0012"><inline-formula><mml:math id="M2" altimg="si44.svg"><mml:mrow><mml:mi>S</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> is the Susceptible compartment that counts the number of individuals susceptible but still not infected by the disease;</p></list-item><list-item id="lstitem0007"><label>•</label><p id="p0013"><inline-formula><mml:math id="M3" altimg="si45.svg"><mml:mrow><mml:mi>I</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> is the Infectious compartment that counts the number of infectious individuals;</p></list-item><list-item id="lstitem0008"><label>•</label><p id="p0014"><inline-formula><mml:math id="M4" altimg="si46.svg"><mml:mrow><mml:mi>R</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> is the Removed compartment. It represents the number of those who can no longer be infected either because they recovered and gained long-term immunity or because they passed away.</p></list-item></list>
</p>
              <p id="p0015">The model involves two positive parameters, <inline-formula><mml:math id="M5" altimg="si47.svg"><mml:mi>β</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="M6" altimg="si29.svg"><mml:mi>γ</mml:mi></mml:math></inline-formula> which govern the flow from one compartment to the other:<list list-type="simple" id="lst0001"><list-item id="lstitem0009"><label>-</label><p id="p0016"><inline-formula><mml:math id="M7" altimg="si47.svg"><mml:mi>β</mml:mi></mml:math></inline-formula> is the transmission rate or effective contact rate of the disease: an infected individual comes into contact with <inline-formula><mml:math id="M8" altimg="si47.svg"><mml:mi>β</mml:mi></mml:math></inline-formula> other individuals per unit time (the fraction that are susceptible to contracting the disease is <inline-formula><mml:math id="M9" altimg="si48.svg"><mml:mrow><mml:mi>S</mml:mi><mml:mo linebreak="goodbreak">/</mml:mo><mml:mi>N</mml:mi></mml:mrow></mml:math></inline-formula>);</p></list-item><list-item id="lstitem0010"><label>-</label><p id="p0017"><inline-formula><mml:math id="M10" altimg="si29.svg"><mml:mi>γ</mml:mi></mml:math></inline-formula> is the removal rate. <inline-formula><mml:math id="M11" altimg="si49.svg"><mml:msup><mml:mi>γ</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula> is the mean number of days who is infected spends in the Infectious compartment.</p></list-item></list>
</p>
              <p id="p0018">The SIR model obeys the following system of ordinary differential equations (ODE):<disp-formula id="eq0002"><label>(1a)</label><mml:math id="M12" altimg="si50.svg"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mrow><mml:mo>=</mml:mo><mml:mi>β</mml:mi><mml:mi>I</mml:mi><mml:mfrac><mml:mi>S</mml:mi><mml:mi>N</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">−</mml:mo><mml:mi>γ</mml:mi><mml:mi>I</mml:mi></mml:mrow></mml:math></disp-formula>
<disp-formula id="eq0003"><label>(1b)</label><mml:math id="M13" altimg="si51.svg"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mrow><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mi>β</mml:mi><mml:mi>I</mml:mi><mml:mfrac><mml:mi>S</mml:mi><mml:mi>N</mml:mi></mml:mfrac></mml:mrow></mml:math></disp-formula>
<disp-formula id="eq0004"><label>(1c)</label><mml:math id="M14" altimg="si52.svg"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mrow><mml:mo>=</mml:mo><mml:mi>γ</mml:mi><mml:mi>I</mml:mi></mml:mrow></mml:math></disp-formula>
</p>
              <p id="p0019">Although the SIR model has been adopted to study epidemic outbreaks in many previous works <xref rid="bib0002" ref-type="bibr">[2]</xref>, <xref rid="bib0022" ref-type="bibr">[22]</xref>, <xref rid="bib0023" ref-type="bibr">[23]</xref>, <xref rid="bib0024" ref-type="bibr">[24]</xref>, <xref rid="bib0025" ref-type="bibr">[25]</xref>, <xref rid="bib0026" ref-type="bibr">[26]</xref>, <xref rid="bib0027" ref-type="bibr">[27]</xref>, it lacks few important aspects of the current ongoing pandemic. First of all, it has been reported <xref rid="bib0028" ref-type="bibr">[28]</xref>, <xref rid="bib0029" ref-type="bibr">[29]</xref> that an important fraction of those who are carrying the virus is asymptomatic. Since they often avoid contact tracing due to the absence of symptoms, they can spread the disease while remaining undetected. Furthermore, in December 2020 a global vaccination campaign has started. Vaccinating is a safe way to transfer people from the Susceptible to the Removed compartment bypassing the Infectious one thus reducing the likelihood of an outbreak.</p>
              <p id="p0020">The SAIVR model extends the SIR model by incorporating the two aforementioned additional compartments:<list list-type="simple" id="lst0005"><list-item id="lstitem0011"><label>•</label><p id="p0021"><inline-formula><mml:math id="M15" altimg="si53.svg"><mml:mrow><mml:mi>A</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> is the Asymptomatic/Undetected compartment that counts the number of those individuals that despite being infected are not tested/traced. This mainly occurs to those who recover from the infection without suffering any symptoms.</p></list-item><list-item id="lstitem0012"><label>•</label><p id="p0022"><inline-formula><mml:math id="M16" altimg="si54.svg"><mml:mrow><mml:mi>V</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> is the Vaccinated compartment. It takes into account those that have received a vaccine shot but are still not fully immunized by it.</p></list-item></list>
</p>
              <p id="p0023">We emphasize that in the SAIVR model the fully vaccinated population is already included in the model as part of the ‘Removed’ compartment, while the ‘Vaccinated’ population is an additional compartment that adds further predictive power to the model by taking into consideration the fact that it takes a few weeks (often due to the necessity of a second vaccine shot) to reach full immunization; full immunization, in the context of the model, is equivalent to moving a person to the ‘Removed’ compartment.</p>
              <p id="p0024">The SAIVR model ODEs read:<disp-formula id="eq0006"><label>(2a)</label><mml:math id="M17" altimg="si55.svg"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>I</mml:mi><mml:mfrac><mml:mi>S</mml:mi><mml:mi>N</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>A</mml:mi><mml:mfrac><mml:mi>S</mml:mi><mml:mi>N</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">+</mml:mo><mml:mi>ζ</mml:mi><mml:mi>I</mml:mi><mml:mfrac><mml:mi>V</mml:mi><mml:mi>N</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">−</mml:mo><mml:mi>γ</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>
<disp-formula id="eq0007"><label>(2b)</label><mml:math id="M18" altimg="si56.svg"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>A</mml:mi><mml:mfrac><mml:mi>S</mml:mi><mml:mi>N</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>I</mml:mi><mml:mfrac><mml:mi>S</mml:mi><mml:mi>N</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">+</mml:mo><mml:mi>η</mml:mi><mml:mi>A</mml:mi><mml:mfrac><mml:mi>V</mml:mi><mml:mi>N</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">−</mml:mo><mml:mi>γ</mml:mi><mml:mi>A</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>
<disp-formula id="eq0008"><label>(2c)</label><mml:math id="M19" altimg="si57.svg"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo linebreak="goodbreak">=</mml:mo><mml:mo>−</mml:mo><mml:mi>β</mml:mi><mml:mi>I</mml:mi><mml:mfrac><mml:mi>S</mml:mi><mml:mi>N</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">−</mml:mo><mml:mi>α</mml:mi><mml:mi>A</mml:mi><mml:mfrac><mml:mi>S</mml:mi><mml:mi>N</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">−</mml:mo><mml:mi>δ</mml:mi><mml:mfrac><mml:mi>S</mml:mi><mml:mi>N</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">−</mml:mo><mml:mi>λ</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mi>ϵ</mml:mi><mml:mi>V</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>
<disp-formula id="eq0009"><label>(2d)</label><mml:math id="M20" altimg="si58.svg"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo linebreak="goodbreak">=</mml:mo><mml:mi>δ</mml:mi><mml:mfrac><mml:mi>S</mml:mi><mml:mi>N</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">−</mml:mo><mml:mi>η</mml:mi><mml:mi>A</mml:mi><mml:mfrac><mml:mi>V</mml:mi><mml:mi>N</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">−</mml:mo><mml:mi>ζ</mml:mi><mml:mi>I</mml:mi><mml:mfrac><mml:mi>V</mml:mi><mml:mi>N</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">−</mml:mo><mml:mi>ϵ</mml:mi><mml:mi>V</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>
<disp-formula id="eq0010"><label>(2e)</label><mml:math id="M21" altimg="si59.svg"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo linebreak="goodbreak">=</mml:mo><mml:mi>γ</mml:mi><mml:mi>I</mml:mi><mml:mo linebreak="goodbreak">+</mml:mo><mml:mi>γ</mml:mi><mml:mi>A</mml:mi><mml:mo linebreak="goodbreak">+</mml:mo><mml:mi>λ</mml:mi><mml:mi>ϵ</mml:mi><mml:mi>V</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula>
</p>
              <p id="p0025">The compartment inter-dependencies and flow are presented in <xref rid="fig0001" ref-type="fig">Fig. 1</xref>
. The parameters of the SAIVR model are the following:<list list-type="simple" id="lst0002"><list-item id="lstitem0013"><label>-</label><p id="p0026"><inline-formula><mml:math id="M22" altimg="si28.svg"><mml:msub><mml:mi>β</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></inline-formula> describes the rate at which individuals are exposed to symptomatic infection. An infected symptomatic individual comes into contact and infects <inline-formula><mml:math id="M23" altimg="si28.svg"><mml:msub><mml:mi>β</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></inline-formula> susceptible individuals per unit time;</p></list-item><list-item id="lstitem0014"><label>-</label><p id="p0027"><inline-formula><mml:math id="M24" altimg="si30.svg"><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></inline-formula> is the asymptomatic infection rate. An infected asymptomatic individual comes into contact with <inline-formula><mml:math id="M25" altimg="si30.svg"><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></inline-formula> susceptible individuals per unit time;</p></list-item><list-item id="lstitem0015"><label>-</label><p id="p0028"><inline-formula><mml:math id="M26" altimg="si40.svg"><mml:msub><mml:mi>β</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></inline-formula> describes the rate at which susceptible individuals become asymptomatic infected after entering in contact with a symptomatic individual;</p></list-item><list-item id="lstitem0016"><label>-</label><p id="p0029"><inline-formula><mml:math id="M27" altimg="si41.svg"><mml:msub><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></inline-formula> describes the rate at which who’s susceptible becomes symptomatic after entering in contact with an asymptomatic individual;</p></list-item><list-item id="lstitem0017"><label>-</label><p id="p0030"><inline-formula><mml:math id="M28" altimg="si29.svg"><mml:mi>γ</mml:mi></mml:math></inline-formula> retains the same meaning as in the SIR model, representing the mean removal rate. <inline-formula><mml:math id="M29" altimg="si49.svg"><mml:msup><mml:mi>γ</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula> is the mean amount of time individuals spend either in the Infectious or Asymptomatic compartments;</p></list-item><list-item id="lstitem0018"><label>-</label><p id="p0031"><inline-formula><mml:math id="M30" altimg="si39.svg"><mml:mi>ζ</mml:mi></mml:math></inline-formula> is the rate at which a vaccinated (but still not immune) individual enters in contact with a symptomatic infectious;</p></list-item><list-item id="lstitem0019"><label>-</label><p id="p0032"><inline-formula><mml:math id="M31" altimg="si38.svg"><mml:mi>η</mml:mi></mml:math></inline-formula> describes the transmission rate at which who’s asymptomatic comes into contact and infects vaccinated (but still not immune) individuals;</p></list-item><list-item id="lstitem0020"><label>-</label><p id="p0033"><inline-formula><mml:math id="M32" altimg="si13.svg"><mml:mi>δ</mml:mi></mml:math></inline-formula> is the first shot vaccination rate;</p></list-item><list-item id="lstitem0021"><label>-</label><p id="p0034"><inline-formula><mml:math id="M33" altimg="si14.svg"><mml:mi>λ</mml:mi></mml:math></inline-formula> is the vaccine efficacy;</p></list-item><list-item id="lstitem0022"><label>-</label><p id="p0035"><inline-formula><mml:math id="M34" altimg="si60.svg"><mml:msup><mml:mi>ϵ</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula> is the mean amount of time an individual spends in the Vaccinated compartment before reaching immunity and moving to the Removed compartment.</p></list-item></list>
<fig id="fig0001"><label>Fig. 1</label><caption><p>Illustration of the SAIVR model compartments and their inter-dependencies denoted by incoming and outgoing arrows and relevant flow parameters.</p></caption><alt-text id="at0001">Fig. 1</alt-text><graphic xlink:href="gr1_lrg"/></fig></p>
              <p id="p0036">Countries and states do not respond to the disease as static entities passively facing the pandemic. They react by actively imposing (and relaxing) restrictive measures, learning how to effectively treat the infected, adjusting social interactions and by launching vaccination campaigns. Finally, the virus itself evolves in more infectious variants <xref rid="bib0030" ref-type="bibr">[30]</xref>.</p>
              <p id="p0037">Country-specific parameters can be obtained by fitting the SAIVR model to a selected infectious wave occurred in a given country. SAIVR has 14 adjustable parameters or initial conditions that needs to be estimated; given the scarcity of data (only the infectious and vaccinated populations are known) optimizing them presents a challenging problem. To address this, we either fixed some of them or employed a novel fitting method based on semi-supervised neural networks, which we present in the following section.</p>
            </sec>
            <sec id="sec0003">
              <label>3</label>
              <title>Solving the SAIVR model with neural networks</title>
              <p id="p0038">In order to apply the SAIVR model we need a realistic estimate of the parameters and initial conditions for the system of Eq. (2). To obtain them we employed machine learning, a powerful method which has been extensively used for disease modeling <xref rid="bib0021" ref-type="bibr">[21]</xref>, <xref rid="bib0031" ref-type="bibr">[31]</xref>, <xref rid="bib0032" ref-type="bibr">[32]</xref>, <xref rid="bib0033" ref-type="bibr">[33]</xref> and dynamical system forecasting <xref rid="bib0019" ref-type="bibr">[19]</xref>, <xref rid="bib0034" ref-type="bibr">[34]</xref>, <xref rid="bib0035" ref-type="bibr">[35]</xref>. Our approach employs a semi-supervised procedure which determines the optimal set of initial conditions and parameters of the SAIVR model, yielding solutions that best fit a given data-set. A sketch of this procedure is shown in <xref rid="fig0002" ref-type="fig">Fig. 2</xref>
.<fig id="fig0002"><label>Fig. 2</label><caption><p>Semi-supervised network architecture. During the unsupervised procedure (blue box), a time sequence <inline-formula><mml:math id="M35" altimg="si1.svg"><mml:mi>t</mml:mi></mml:math></inline-formula>, a set of initial conditions <inline-formula><mml:math id="M36" altimg="si2.svg"><mml:msub><mml:mi mathvariant="script">Z</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula> and parameter bundles <inline-formula><mml:math id="M37" altimg="si3.svg"><mml:mstyle mathvariant="normal"><mml:mi>Θ</mml:mi></mml:mstyle></mml:math></inline-formula> are fed as an input to a 6 layers fully connected network (FCN). The output of the network <inline-formula><mml:math id="M38" altimg="si4.svg"><mml:msub><mml:mi mathvariant="script">Z</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is multiplied by a function <inline-formula><mml:math id="M39" altimg="si5.svg"><mml:mrow><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> to become a tentative parametric solution <inline-formula><mml:math id="M40" altimg="si6.svg"><mml:mrow><mml:mover accent="true"><mml:mi mathvariant="script">Z</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> of the system of ODE in Eq. (2). The quality of <inline-formula><mml:math id="M41" altimg="si6.svg"><mml:mrow><mml:mover accent="true"><mml:mi mathvariant="script">Z</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> is probed by the loss function <inline-formula><mml:math id="M42" altimg="si7.svg"><mml:mi mathvariant="script">L</mml:mi></mml:math></inline-formula>. When the network has learned the solutions, the inverse problem is then solved (red box). An optimization algorithm selects the initial conditions and parameters in the bundle that best fit a given data-set. The loss <inline-formula><mml:math id="M43" altimg="si8.svg"><mml:msub><mml:mi mathvariant="script">L</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>v</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> depends on the infectious population of a given country/state <inline-formula><mml:math id="M44" altimg="si9.svg"><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>D</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> during the time sequence <inline-formula><mml:math id="M45" altimg="si1.svg"><mml:mi>t</mml:mi></mml:math></inline-formula>. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)</p></caption><alt-text id="at0002">Fig. 2</alt-text><graphic xlink:href="gr2_lrg"/></fig></p>
              <sec id="sec0004">
                <label>3.1</label>
                <title>Unsupervised learning</title>
                <p id="p0039">The unsupervised part (blue box) consists of a data-free Neural Network (NN) that is trained to discover solutions for an ODE system of the form:<disp-formula id="eq0011"><label>(3)</label><mml:math id="M46" altimg="si61.svg"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi mathvariant="script">Z</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo linebreak="goodbreak">=</mml:mo><mml:mi>g</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi mathvariant="script">Z</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mspace width="0.28em"/><mml:mspace width="0.28em"/><mml:mspace width="0.28em"/><mml:mspace width="0.28em"/><mml:mspace width="0.28em"/><mml:mspace width="0.28em"/><mml:mspace width="0.28em"/><mml:mspace width="0.28em"/><mml:mspace width="0.28em"/><mml:mspace width="0.28em"/><mml:mspace width="0.28em"/><mml:mspace width="0.28em"/><mml:mspace width="0.28em"/><mml:mspace width="0.28em"/><mml:mspace width="0.28em"/><mml:mspace width="0.28em"/><mml:mspace width="0.28em"/><mml:mi mathvariant="script">Z</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>0</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi mathvariant="script">Z</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula>where <inline-formula><mml:math id="M47" altimg="si62.svg"><mml:mrow><mml:mi mathvariant="script">Z</mml:mi><mml:mo linebreak="goodbreak">=</mml:mo><mml:mo>(</mml:mo><mml:mi>S</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>,</mml:mo><mml:mi>A</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>,</mml:mo><mml:mi>I</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>,</mml:mo><mml:mi>V</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>,</mml:mo><mml:mi>R</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M48" altimg="si63.svg"><mml:mrow><mml:mi>g</mml:mi><mml:mo>(</mml:mo><mml:mi mathvariant="script">Z</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> is given in Eq. (2). The NN takes as an input a time sequence <inline-formula><mml:math id="M49" altimg="si1.svg"><mml:mi>t</mml:mi></mml:math></inline-formula>, a set of initial conditions <inline-formula><mml:math id="M50" altimg="si2.svg"><mml:msub><mml:mi mathvariant="script">Z</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula>, and modeling parameters <inline-formula><mml:math id="M51" altimg="si3.svg"><mml:mstyle mathvariant="normal"><mml:mi>Θ</mml:mi></mml:mstyle></mml:math></inline-formula>.</p>
                <p id="p0040">As we’ll see in the following, <inline-formula><mml:math id="M52" altimg="si1.svg"><mml:mi>t</mml:mi></mml:math></inline-formula> is the set of days involved in a given epidemic wave going from <inline-formula><mml:math id="M53" altimg="si64.svg"><mml:msub><mml:mi>t</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula> to <inline-formula><mml:math id="M54" altimg="si65.svg"><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:mstyle mathvariant="normal"><mml:mi>Δ</mml:mi></mml:mstyle><mml:mi>t</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M55" altimg="si66.svg"><mml:msub><mml:mi>Z</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula> are the initial compartment populations and <inline-formula><mml:math id="M56" altimg="si3.svg"><mml:mstyle mathvariant="normal"><mml:mi>Θ</mml:mi></mml:mstyle></mml:math></inline-formula> some parameters of the SAIVR model. The initial conditions and parameters are randomly sampled at each iteration <inline-formula><mml:math id="M57" altimg="si67.svg"><mml:mi>n</mml:mi></mml:math></inline-formula> over predefined intervals called bundles <xref rid="bib0019" ref-type="bibr">[19]</xref>, <xref rid="bib0021" ref-type="bibr">[21]</xref>, so that the network learns an entire family of solutions. The inputs propagate through the network until an output vector <inline-formula><mml:math id="M58" altimg="si4.svg"><mml:msub><mml:mi mathvariant="script">Z</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> of the same dimensions as the target solutions <inline-formula><mml:math id="M59" altimg="si68.svg"><mml:mi mathvariant="script">Z</mml:mi></mml:math></inline-formula> is produced. The learned solutions <inline-formula><mml:math id="M60" altimg="si69.svg"><mml:mover accent="true"><mml:mi mathvariant="script">Z</mml:mi><mml:mo>^</mml:mo></mml:mover></mml:math></inline-formula> satisfy the initial conditions identically by considering parametric solutions of the form:<disp-formula id="eq0012"><label>(4)</label><mml:math id="M61" altimg="si70.svg"><mml:mrow><mml:mover accent="true"><mml:mi mathvariant="script">Z</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi mathvariant="script">Z</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:mi>f</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi mathvariant="script">Z</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="badbreak">−</mml:mo><mml:msub><mml:mi mathvariant="script">Z</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula>where <inline-formula><mml:math id="M62" altimg="si71.svg"><mml:mrow><mml:mi>f</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:math></inline-formula>
<xref rid="bib0020" ref-type="bibr">[20]</xref>. The loss function:<disp-formula id="eq0013"><label>(5)</label><mml:math id="M63" altimg="si72.svg"><mml:mrow><mml:mi mathvariant="script">L</mml:mi><mml:mo linebreak="goodbreak">=</mml:mo><mml:mo stretchy="true">〈</mml:mo><mml:msup><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi mathvariant="script">Z</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>−</mml:mo><mml:mi>g</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi mathvariant="script">Z</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy="true">〉</mml:mo></mml:mrow></mml:math></disp-formula>solely depends on the network predictions averaged (<inline-formula><mml:math id="M64" altimg="si73.svg"><mml:mrow><mml:mo>〈</mml:mo><mml:mo>…</mml:mo><mml:mo>〉</mml:mo></mml:mrow></mml:math></inline-formula>) over all the iterations <inline-formula><mml:math id="M65" altimg="si67.svg"><mml:mi>n</mml:mi></mml:math></inline-formula>, providing an unsupervised learning framework. Time derivatives are computed using the automatic-differentiation and back-propagation techniques <xref rid="bib0036" ref-type="bibr">[36]</xref>.</p>
              </sec>
              <sec id="sec0005">
                <label>3.2</label>
                <title>Fitting a dataset</title>
                <p id="p0041">Once the NN is trained to provide solutions for the system of Eq. (2), its weights and biases are fixed and the trained network is used to develop a supervised pipeline for the estimation of the initial conditions and parameters, leading to solutions <inline-formula><mml:math id="M66" altimg="si74.svg"><mml:mrow><mml:mover accent="true"><mml:mi mathvariant="script">Z</mml:mi><mml:mo>˜</mml:mo></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> that fit given data. This procedure is illustrated in the red box in <xref rid="fig0002" ref-type="fig">Fig. 2</xref>. A solution <inline-formula><mml:math id="M67" altimg="si69.svg"><mml:mover accent="true"><mml:mi mathvariant="script">Z</mml:mi><mml:mo>^</mml:mo></mml:mover></mml:math></inline-formula> is generated by the network starting from <inline-formula><mml:math id="M68" altimg="si75.svg"><mml:mover accent="true"><mml:msub><mml:mi mathvariant="script">Z</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>¯</mml:mo></mml:mover></mml:math></inline-formula> and <inline-formula><mml:math id="M69" altimg="si76.svg"><mml:mover accent="true"><mml:mstyle mathvariant="normal"><mml:mi>Θ</mml:mi></mml:mstyle><mml:mo>¯</mml:mo></mml:mover></mml:math></inline-formula> randomly selected in the bundles. A stochastic gradient descent optimizer then adjusts <inline-formula><mml:math id="M70" altimg="si75.svg"><mml:mover accent="true"><mml:msub><mml:mi mathvariant="script">Z</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>¯</mml:mo></mml:mover></mml:math></inline-formula> and <inline-formula><mml:math id="M71" altimg="si76.svg"><mml:mover accent="true"><mml:mstyle mathvariant="normal"><mml:mi>Θ</mml:mi></mml:mstyle><mml:mo>¯</mml:mo></mml:mover></mml:math></inline-formula> in order to minimize the loss function:<disp-formula id="eq0014"><label>(6)</label><mml:math id="M72" altimg="si77.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">L</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mo stretchy="true">〈</mml:mo><mml:msup><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mover accent="true"><mml:mi>I</mml:mi><mml:mo>˜</mml:mo></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>D</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy="true">〉</mml:mo></mml:mrow></mml:math></disp-formula>where <inline-formula><mml:math id="M73" altimg="si78.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>D</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> is the infectious population of a given country/state and <inline-formula><mml:math id="M74" altimg="si79.svg"><mml:mrow><mml:mover accent="true"><mml:mi>I</mml:mi><mml:mo>˜</mml:mo></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> is its NN fit.</p>
                <p id="p0042">The machine learning approach presented in this work provides numerical solutions to a nonlinear system of ODEs without statistical error (no data is used in the first part of the process). The supervised part is only learning what are the best parameters/conditions of the SAIVR model that fits given data, so the statistical error of the noisy data does not affect the final outcome of the process.</p>
              </sec>
              <sec id="sec0006">
                <label>3.3</label>
                <title>Applying the method to real data</title>
                <p id="p0043">We used this method to reproduce the most recent COVID-19 waves in 27 countries or states. To test the generality of the model we selected epidemic waves that occurred in a broad range of geopolitical conditions, restrictive measures, time periods and vaccination efforts. The bundles and fixed parameters used during the unsupervised training of the network are listed in <xref rid="tbl0001" ref-type="table">Table. 1</xref>
.<table-wrap position="float" id="tbl0001"><label>Table 1</label><caption><p>Bundles and fixed parameters.</p></caption><alt-text id="at0007">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top"><inline-formula><mml:math id="M75" altimg="si24.svg"><mml:msub><mml:mi>I</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula></th><th align="left" valign="top"><inline-formula><mml:math id="M76" altimg="si25.svg"><mml:msub><mml:mi>A</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula></th><th align="left" valign="top"><inline-formula><mml:math id="M77" altimg="si26.svg"><mml:msub><mml:mi>V</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula></th><th align="left" valign="top"><inline-formula><mml:math id="M78" altimg="si27.svg"><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula></th><th align="left" valign="top"><inline-formula><mml:math id="M79" altimg="si28.svg"><mml:msub><mml:mi>β</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></inline-formula></th><th align="left" valign="top"><inline-formula><mml:math id="M80" altimg="si29.svg"><mml:mi>γ</mml:mi></mml:math></inline-formula></th><th align="left" valign="top"><inline-formula><mml:math id="M81" altimg="si30.svg"><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></inline-formula></th><th align="left" valign="top"><inline-formula><mml:math id="M82" altimg="si13.svg"><mml:mi>δ</mml:mi></mml:math></inline-formula></th></tr></thead><tbody><tr><td valign="top"><inline-formula><mml:math id="M83" altimg="si31.svg"><mml:mrow><mml:mo>[</mml:mo><mml:mn>0.1</mml:mn><mml:mo>%</mml:mo><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>%</mml:mo><mml:mo>]</mml:mo></mml:mrow></mml:math></inline-formula></td><td valign="top"><inline-formula><mml:math id="M84" altimg="si31.svg"><mml:mrow><mml:mo>[</mml:mo><mml:mn>0.1</mml:mn><mml:mo>%</mml:mo><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>%</mml:mo><mml:mo>]</mml:mo></mml:mrow></mml:math></inline-formula></td><td valign="top"><inline-formula><mml:math id="M85" altimg="si32.svg"><mml:mrow><mml:mo>[</mml:mo><mml:mn>0</mml:mn><mml:mo>%</mml:mo><mml:mo>,</mml:mo><mml:mn>60</mml:mn><mml:mo>%</mml:mo><mml:mo>]</mml:mo></mml:mrow></mml:math></inline-formula></td><td valign="top"><inline-formula><mml:math id="M86" altimg="si33.svg"><mml:mrow><mml:mo>[</mml:mo><mml:mn>0</mml:mn><mml:mo>%</mml:mo><mml:mo>,</mml:mo><mml:mn>30</mml:mn><mml:mo>%</mml:mo><mml:mo>]</mml:mo></mml:mrow></mml:math></inline-formula></td><td valign="top"><inline-formula><mml:math id="M87" altimg="si34.svg"><mml:mrow><mml:mo>[</mml:mo><mml:mn>0.1</mml:mn><mml:mo>,</mml:mo><mml:mn>0.25</mml:mn><mml:mo>]</mml:mo></mml:mrow></mml:math></inline-formula></td><td valign="top"><inline-formula><mml:math id="M88" altimg="si35.svg"><mml:mrow><mml:mo>[</mml:mo><mml:mn>0.07</mml:mn><mml:mo>,</mml:mo><mml:mn>0.12</mml:mn><mml:mo>]</mml:mo></mml:mrow></mml:math></inline-formula></td><td valign="top"><inline-formula><mml:math id="M89" altimg="si34.svg"><mml:mrow><mml:mo>[</mml:mo><mml:mn>0.1</mml:mn><mml:mo>,</mml:mo><mml:mn>0.25</mml:mn><mml:mo>]</mml:mo></mml:mrow></mml:math></inline-formula></td><td valign="top"><inline-formula><mml:math id="M90" altimg="si36.svg"><mml:mrow><mml:mo>[</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>0.03</mml:mn><mml:mo>]</mml:mo></mml:mrow></mml:math></inline-formula></td></tr><tr><td valign="top"><inline-formula><mml:math id="M91" altimg="si37.svg"><mml:mi>ϵ</mml:mi></mml:math></inline-formula></td><td valign="top"><inline-formula><mml:math id="M92" altimg="si14.svg"><mml:mi>λ</mml:mi></mml:math></inline-formula></td><td valign="top"><inline-formula><mml:math id="M93" altimg="si38.svg"><mml:mi>η</mml:mi></mml:math></inline-formula></td><td valign="top"><inline-formula><mml:math id="M94" altimg="si39.svg"><mml:mi>ζ</mml:mi></mml:math></inline-formula></td><td valign="top"><inline-formula><mml:math id="M95" altimg="si40.svg"><mml:msub><mml:mi>β</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></inline-formula></td><td valign="top"><inline-formula><mml:math id="M96" altimg="si41.svg"><mml:msub><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></inline-formula></td><td/><td/></tr><tr><td valign="top">1/21</td><td valign="top">0.95</td><td valign="top">1e<inline-formula><mml:math id="M97" altimg="si42.svg"><mml:mo>−</mml:mo></mml:math></inline-formula>2</td><td valign="top">5e<inline-formula><mml:math id="M98" altimg="si42.svg"><mml:mo>−</mml:mo></mml:math></inline-formula>3</td><td valign="top">1e<inline-formula><mml:math id="M99" altimg="si42.svg"><mml:mo>−</mml:mo></mml:math></inline-formula>3</td><td valign="top">1e<inline-formula><mml:math id="M100" altimg="si42.svg"><mml:mo>−</mml:mo></mml:math></inline-formula>2</td><td/><td/></tr></tbody></table></table-wrap></p>
                <p id="p0044">We found that the model is weakly sensitive on the choice of most parameters and thus, we kept some of them fixed during the training. The value of the vaccine efficacy <inline-formula><mml:math id="M101" altimg="si14.svg"><mml:mi>λ</mml:mi></mml:math></inline-formula> is based on Refs. <xref rid="bib0037" ref-type="bibr">[37]</xref>, <xref rid="bib0038" ref-type="bibr">[38]</xref>, where a vaccine efficacy of <inline-formula><mml:math id="M102" altimg="si80.svg"><mml:mrow><mml:mn>94.8</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M103" altimg="si81.svg"><mml:mrow><mml:mn>94.1</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> is reported for the Pfizer-BioNTech and Moderna mRNA vaccines. The <inline-formula><mml:math id="M104" altimg="si82.svg"><mml:mrow><mml:mi>V</mml:mi><mml:mo>→</mml:mo><mml:mi>I</mml:mi></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M105" altimg="si83.svg"><mml:mrow><mml:mi>V</mml:mi><mml:mo>→</mml:mo><mml:mi>A</mml:mi></mml:mrow></mml:math></inline-formula> rates <inline-formula><mml:math id="M106" altimg="si39.svg"><mml:mi>ζ</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="M107" altimg="si38.svg"><mml:mi>η</mml:mi></mml:math></inline-formula> are derived by considering the order-of-magnitude ratio of the infected individuals in the vaccinated and placebo cohorts of Ref. <xref rid="bib0037" ref-type="bibr">[37]</xref>, with <inline-formula><mml:math id="M108" altimg="si40.svg"><mml:msub><mml:mi>β</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="M109" altimg="si41.svg"><mml:msub><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></inline-formula> set to 0.001 and 0.01 respectively, which are in order-of-magnitude agreement with the aforementioned results of the clinical trials. The <inline-formula><mml:math id="M110" altimg="si84.svg"><mml:mrow><mml:mi>V</mml:mi><mml:mo>→</mml:mo><mml:mi>R</mml:mi></mml:mrow></mml:math></inline-formula> rate <inline-formula><mml:math id="M111" altimg="si37.svg"><mml:mi>ϵ</mml:mi></mml:math></inline-formula> is the inverse time an individual takes to acquire vaccine protection after the first shot. We set it to <inline-formula><mml:math id="M112" altimg="si85.svg"><mml:mrow><mml:msup><mml:mi>ϵ</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>21</mml:mn></mml:mrow></mml:math></inline-formula> to reflect the fact that the second shot of vaccines is usually administered about three weeks after the first one.</p>
                <p id="p0045">The remaining parameters <inline-formula><mml:math id="M113" altimg="si86.svg"><mml:mrow><mml:mstyle mathvariant="normal"><mml:mi>Θ</mml:mi></mml:mstyle><mml:mo linebreak="goodbreak">=</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi>δ</mml:mi><mml:mo>,</mml:mo><mml:mi>γ</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> strongly depend on what kind of restrictive measures are taken or how fast the vaccination campaign is, i.e. they are country dependent. We therefore selected them in bundles so that the network could learn solutions corresponding to a broad range of parameters and fit multiple countries. The decay rate <inline-formula><mml:math id="M114" altimg="si29.svg"><mml:mi>γ</mml:mi></mml:math></inline-formula> is the inverse of the removal time which is about 1–2 weeks <xref rid="bib0039" ref-type="bibr">[39]</xref>. The main symptomatic infection rate <inline-formula><mml:math id="M115" altimg="si28.svg"><mml:msub><mml:mi>β</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></inline-formula> was sampled in an interval consistent with previous reports <xref rid="bib0002" ref-type="bibr">[2]</xref>. The earlier estimates that <inline-formula><mml:math id="M116" altimg="si87.svg"><mml:mrow><mml:mn>80</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> of infected population is asymptomatic has been considered too high and have since been revised down <xref rid="bib0028" ref-type="bibr">[28]</xref>, <xref rid="bib0029" ref-type="bibr">[29]</xref>; the initial studies estimating this proportion were limited by heterogeneity in case definitions, incomplete symptom assessment, and inadequate retrospective and prospective follow-up of symptoms. We selected the main asymptomatic infection rate <inline-formula><mml:math id="M117" altimg="si30.svg"><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></inline-formula> to be varying in the same interval of <inline-formula><mml:math id="M118" altimg="si28.svg"><mml:msub><mml:mi>β</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></inline-formula>. The first shot vaccination rate <inline-formula><mml:math id="M119" altimg="si13.svg"><mml:mi>δ</mml:mi></mml:math></inline-formula> was selected based on known vaccination reports (see <xref rid="sec0011" ref-type="sec">Appendix A</xref>).</p>
                <p id="p0046">Finally, the initial condition bundles <inline-formula><mml:math id="M120" altimg="si88.svg"><mml:mrow><mml:msub><mml:mi mathvariant="script">Z</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> are defined over broad intervals able to cover the expected (<inline-formula><mml:math id="M121" altimg="si89.svg"><mml:mrow><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>A</mml:mi><mml:mo>,</mml:mo><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mi>V</mml:mi><mml:mo>,</mml:mo><mml:mi>R</mml:mi></mml:mrow></mml:math></inline-formula>) populations at any given time for all the cases considered. Although the initial infected population <inline-formula><mml:math id="M122" altimg="si24.svg"><mml:msub><mml:mi>I</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula> is known, we still included it in the set of quantities to be fit by the network. We found that by doing so, the network generalizes better improving the fit of a given epidemic wave.</p>
                <p id="p0047">We then performed the fitting procedure described in <xref rid="sec0005" ref-type="sec">Sectiion 3.2</xref> using the infectious populations of 27 countries/states. The data (including the number of vaccine shots administered) is retrieved from the ‘Our World in Data’ GitHub repository <xref rid="bib0040" ref-type="bibr">[40]</xref>. Strictly speaking, the Infectious population of the SAIVR model is the amount of people that are actively infected by the virus on a given day, a number that should not be confused with the daily new cases. As such, it was computed as the difference between the total number of cases and of recovered/dead individuals.</p>
                <p id="p0048">We first applied the method to study the most recent COVID-19 wave in some of the countries with the fastest vaccination campaigns and that managed to inoculate the first shot in at least <inline-formula><mml:math id="M123" altimg="si90.svg"><mml:mrow><mml:mn>30</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> of their population. <xref rid="fig0003" ref-type="fig">Fig. 3</xref>
presents real data (red points), fits (black solid line), and some predictions (black dashed line) for the infectious populations of Israel, UK, Hungary, France, Romania and Serbia. We also studied the USA, although due to the large size of the country we focused only on the largest states or those with the highest vaccination rates in the first quarter 2021, see <xref rid="fig0004" ref-type="fig">Fig. 4</xref>
. To assess the generality of the model and the fitting procedure, we applied it to other 12 countries spread throughout the world and which had at the end of spring 2021 a high number of cases. The corresponding fits are shown in Figs. S1 and S2 of the <bold>Supplementary Material</bold>. As can be seen, the model is able to well reproduce all these epidemic curves despite missing some abrupt and rapid events that can be captured by more sophisticated multiple-wave models <xref rid="bib0002" ref-type="bibr">[2]</xref>. All the parameters determined by the network can be found in the <bold>Supplementary Material</bold>; their values are within the bundles of <xref rid="tbl0001" ref-type="table">Table 1</xref>. In particular, <inline-formula><mml:math id="M124" altimg="si29.svg"><mml:mi>γ</mml:mi></mml:math></inline-formula> was found in the 10–12 days range, <inline-formula><mml:math id="M125" altimg="si28.svg"><mml:msub><mml:mi>β</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></inline-formula> oscillating in [0.14–0.19] while alpha was more volatile.<fig id="fig0003"><label>Fig. 3</label><caption><p>Infectious population percentage (red dots) of some selected countries in which a high percentage of their population has received a vaccine shot. The infectious population is expressed as a function of time (days). The date at which the wave began is pointed out on the horizontal axis. The neural network fits and predictions are shown by black solid and dashed lines respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)</p></caption><alt-text id="at0003">Fig. 3</alt-text><graphic xlink:href="gr3_lrg"/></fig><fig id="fig0004"><label>Fig. 4</label><caption><p>Infectious population percentage (red dots) of ten selected US states. The infectious population is expressed as a function of time (days). The date at which the wave began is pointed out on the horizontal axis. The neural network fits and predictions are shown by black solid and dashed lines respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)</p></caption><alt-text id="at0004">Fig. 4</alt-text><graphic xlink:href="gr4_lrg"/></fig></p>
              </sec>
            </sec>
            <sec id="sec0007">
              <label>4</label>
              <title>Insights on the future: vaccine hesitancy, herd immunity and new variants</title>
              <p id="p0049">In this section we use the results of the analysis performed in the previous section to study how the vaccination campaign is affecting the pandemic and its future evolution. Unless otherwise specified, we set <inline-formula><mml:math id="M126" altimg="si17.svg"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>0.16</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M127" altimg="si91.svg"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M128" altimg="si92.svg"><mml:mrow><mml:mi>γ</mml:mi><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">/</mml:mo><mml:mn>12</mml:mn></mml:mrow></mml:math></inline-formula>, the average values retrieved from fitting real data. We start by pointing out how the vaccine efficacy is a key factor in halting the spread of the virus and how hesitancy is challenging the vaccination campaigns. Finally, we discuss the concept of herd immunity and how it is affected by more infectious COVID-19 variants.</p>
              <sec id="sec0008">
                <label>4.1</label>
                <title>Vaccination efficacy and hesitancy</title>
                <p id="p0050"><xref rid="fig0005" ref-type="fig">Fig. 5</xref> presents the total infected (<inline-formula><mml:math id="M129" altimg="si93.svg"><mml:mrow><mml:mi>I</mml:mi><mml:mo linebreak="goodbreak">+</mml:mo><mml:mi>A</mml:mi></mml:mrow></mml:math></inline-formula>) population under increasing values of vaccination onset times (<inline-formula><mml:math id="M130" altimg="si94.svg"><mml:msub><mml:mi>T</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula>), vaccination daily rates (<inline-formula><mml:math id="M131" altimg="si13.svg"><mml:mi>δ</mml:mi></mml:math></inline-formula>), vaccine efficacy (<inline-formula><mml:math id="M132" altimg="si14.svg"><mml:mi>λ</mml:mi></mml:math></inline-formula>) and of vaccine hesitancy/denial population percentage. In the top panel, total infected population is shown as a function of the vaccination rate <inline-formula><mml:math id="M133" altimg="si13.svg"><mml:mi>δ</mml:mi></mml:math></inline-formula> and vaccine efficacy <inline-formula><mml:math id="M134" altimg="si14.svg"><mml:mi>λ</mml:mi></mml:math></inline-formula>. As can be seen, even vaccines with a relatively low efficacy can rapidly reduce the infected population. In <xref rid="fig0005" ref-type="fig">Fig. 5</xref>b) we show how the number of those infected evolves as a function of <inline-formula><mml:math id="M135" altimg="si13.svg"><mml:mi>δ</mml:mi></mml:math></inline-formula> and the percentage of population that avoids getting vaccinated. These findings suggest that vaccine hesitancy, which accounts for a significant proportion of the population might seriously threaten the reach of herd immunity, especially if the situation is worsened by the appearance of more infectious COVID-19 strains.<fig id="fig0005"><label>Fig. 5</label><caption><p>Total infected population as a function of vaccination rate, vaccine efficacy and vaccine denial population percentage. Results are obtained by numerically solving the SAIVR model for <inline-formula><mml:math id="M136" altimg="si10.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>−</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M137" altimg="si11.svg"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>0.2</mml:mn><mml:mo linebreak="goodbreak">×</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>, where <inline-formula><mml:math id="M138" altimg="si12.svg"><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mn>6</mml:mn></mml:msup></mml:mrow></mml:math></inline-formula>. The parameters of the model used are those obtained by applying machine learning on the epidemic curves. a) Infected population vs. vaccination rate <inline-formula><mml:math id="M139" altimg="si13.svg"><mml:mi>δ</mml:mi></mml:math></inline-formula> and vaccine efficacy <inline-formula><mml:math id="M140" altimg="si14.svg"><mml:mi>λ</mml:mi></mml:math></inline-formula>. b) Infected population as a function of the percentage of the population that avoids getting vaccinated and the vaccine rate <inline-formula><mml:math id="M141" altimg="si13.svg"><mml:mi>δ</mml:mi></mml:math></inline-formula>.</p></caption><alt-text id="at0005">Fig. 5</alt-text><graphic xlink:href="gr5_lrg"/></fig></p>
              </sec>
              <sec id="sec0009">
                <label>4.2</label>
                <title>Herd immunity and new COVID-19 variants</title>
                <p id="p0051">The achievement of herd immunity has been hailed as the ultimate goal of a successful vaccination campaign. ‘Herd immunity’, also known as ‘population immunity’, is the indirect protection from an infectious disease that happens when a sufficient portion of the population is immune either through vaccination or immunity developed through previous infection. Once the herd immunity threshold is met, the spread of the infectious disease is kept under control, current outbreaks will extinguish and endemic transmission of the pathogen will be interrupted. Earlier estimates of the threshold found values of about 60–70% of the population <xref rid="bib0041" ref-type="bibr">[41]</xref>, <xref rid="bib0042" ref-type="bibr">[42]</xref>, <xref rid="bib0043" ref-type="bibr">[43]</xref>. In reality, highly transmissible strains tend to increase the threshold value, possibly keeping this goal out of reach. Furthermore, persistent hesitancy about vaccines makes vaccinating more than the 60–65% of the population unlikely even in countries which are at the global forefront of the vaccination effort.</p>
                <p id="p0052">We quantitatively investigate the likelihood of incurring resurgent COVID-19 epidemics after having immunized <inline-formula><mml:math id="M142" altimg="si21.svg"><mml:mrow><mml:mn>50</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M143" altimg="si22.svg"><mml:mrow><mml:mn>60</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="M144" altimg="si95.svg"><mml:mrow><mml:mn>70</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> of the population, under different new infection introductions, COVID-19 variants and ongoing vaccine deployment pace. Herd immunity protection is affected by the initial value of the removed population (<inline-formula><mml:math id="M145" altimg="si27.svg"><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula> at <inline-formula><mml:math id="M146" altimg="si96.svg"><mml:mrow><mml:mi>t</mml:mi><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula>), which comprises both recovered as well as fully vaccinated individuals, assuming permanent immunity for both cases. In each scenario, we study the epidemic evolution after the introduction of a cluster of newly infected individuals in the population. <inline-formula><mml:math id="M147" altimg="si24.svg"><mml:msub><mml:mi>I</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula> represents the newly infected load at <inline-formula><mml:math id="M148" altimg="si96.svg"><mml:mrow><mml:mi>t</mml:mi><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="M149" altimg="si97.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>1</mml:mn><mml:mo>%</mml:mo><mml:mo>,</mml:mo><mml:mn>0.1</mml:mn><mml:mo>%</mml:mo><mml:mo>,</mml:mo><mml:mn>0.01</mml:mn><mml:mo>%</mml:mo><mml:mo>,</mml:mo><mml:mn>0.001</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> of the total population).</p>
                <p id="p0053">In the first part of the study we considered the less infectious variants spreading during the 2021 spring by using the parameters retrieved in <xref rid="sec0006" ref-type="sec">Section 3.3</xref>. The second scenario involves a more infectious COVID-19 strain such as the Delta variant, which has been reported to be able to spread the virus more efficiently <xref rid="bib0044" ref-type="bibr">[44]</xref>. Finally, we explore cases that involve or not further (continuing) vaccine roll-outs.</p>
                <p id="p0054"><xref rid="fig0006" ref-type="fig">Fig. 6</xref> presents the results obtained by numerically solving the SAIVR model for the aforementioned cases. The top row presents the time evolution of an outbreak in a population where the 50<inline-formula><mml:math id="M150" altimg="si15.svg"><mml:mo>%</mml:mo></mml:math></inline-formula> (left panel), 60<inline-formula><mml:math id="M151" altimg="si15.svg"><mml:mo>%</mml:mo></mml:math></inline-formula> (middle panel), and 70<inline-formula><mml:math id="M152" altimg="si15.svg"><mml:mo>%</mml:mo></mml:math></inline-formula> (right panel) of the individuals have been immunized, for different numbers of initially infected individuals <inline-formula><mml:math id="M153" altimg="si24.svg"><mml:msub><mml:mi>I</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula>. Results are obtained by solving the SAIVR model for <inline-formula><mml:math id="M154" altimg="si17.svg"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>0.16</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M155" altimg="si18.svg"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>0.20</mml:mn></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="M156" altimg="si92.svg"><mml:mrow><mml:mi>γ</mml:mi><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">/</mml:mo><mml:mn>12</mml:mn></mml:mrow></mml:math></inline-formula>; the average values obtained for the countries considered in <xref rid="sec0006" ref-type="sec">Section 3.3</xref> and listed in <bold>Supplementary Material</bold>. As it can be seen, when the immune portion of the population is only <inline-formula><mml:math id="M157" altimg="si21.svg"><mml:mrow><mml:mn>50</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula>, the outbreaks are contained but not eradicated as the virus spreads in low intensity waves making the disease endemic. Given the contagiousness of the less infectious variants, an immunity threshold larger than <inline-formula><mml:math id="M158" altimg="si22.svg"><mml:mrow><mml:mn>60</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> is enough to eradicate the disease.<fig id="fig0006"><label>Fig. 6</label><caption><p><bold>Top row</bold>: Time evolution of epidemics following the introduction of infected individuals in a population that has been already vaccinated at 50<inline-formula><mml:math id="M159" altimg="si15.svg"><mml:mo>%</mml:mo></mml:math></inline-formula> (left panel), 60<inline-formula><mml:math id="M160" altimg="si15.svg"><mml:mo>%</mml:mo></mml:math></inline-formula> (middle panel), and 70<inline-formula><mml:math id="M161" altimg="si15.svg"><mml:mo>%</mml:mo></mml:math></inline-formula> (right panel), with permanent immunity and no further vaccine roll-out, for four different numbers of newly infected individuals (<inline-formula><mml:math id="M162" altimg="si16.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mn>0.001</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> of total population, the color code is presented in the legends). Results are obtained from numerically solving the SAIVR model for <inline-formula><mml:math id="M163" altimg="si17.svg"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>0.16</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M164" altimg="si18.svg"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>0.20</mml:mn></mml:mrow></mml:math></inline-formula>, which represent the average of the countries’ fitted values (see text for details and for the values of the other parameters). <bold>Middle row</bold>: Same as in top row but with <inline-formula><mml:math id="M165" altimg="si19.svg"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>0.25</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="M166" altimg="si20.svg"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>0.25</mml:mn></mml:mrow></mml:math></inline-formula>, which represent a more contagious COVID-19 variant. As is shown, vaccinated coverage of <inline-formula><mml:math id="M167" altimg="si21.svg"><mml:mrow><mml:mn>50</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M168" altimg="si22.svg"><mml:mrow><mml:mn>60</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> cannot prevent the resurgence of outbreaks. <bold>Bottom row</bold>: Same as in middle row, but with ongoing vaccination roll-out with rate <inline-formula><mml:math id="M169" altimg="si23.svg"><mml:mrow><mml:mi>δ</mml:mi><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></inline-formula>, per day, as it is shown, a continuing vaccine roll-out lowers the intensity of the resurgent waves and prevents the resurgence of subsequent outbreaks.</p></caption><alt-text id="at0006">Fig. 6</alt-text><graphic xlink:href="gr6_lrg"/></fig></p>
                <p id="p0055">The middle row of <xref rid="fig0006" ref-type="fig">Fig. 6</xref> presents the evolution of outbreaks driven by a more contagious variant; here <inline-formula><mml:math id="M170" altimg="si19.svg"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>0.25</mml:mn></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="M171" altimg="si20.svg"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>0.25</mml:mn></mml:mrow></mml:math></inline-formula>. As it is shown, if the immunized portion of the population is only <inline-formula><mml:math id="M172" altimg="si21.svg"><mml:mrow><mml:mn>50</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> or <inline-formula><mml:math id="M173" altimg="si22.svg"><mml:mrow><mml:mn>60</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula>, the resurgence of outbreaks cannot be prevented (<inline-formula><mml:math id="M174" altimg="si22.svg"><mml:mrow><mml:mn>60</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> immunity protection makes the disease endemic). Only when the <inline-formula><mml:math id="M175" altimg="si95.svg"><mml:mrow><mml:mn>70</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> of the population is immunized the disease is eradicated.</p>
                <p id="p0056">In both the top and the middle rows, the vaccine deployment is not taking place during the outbreaks. The bottom row instead considers the highly infectious variant disease evolution but with constant vaccine roll-out (with rate <inline-formula><mml:math id="M176" altimg="si23.svg"><mml:mrow><mml:mi>δ</mml:mi><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></inline-formula>). As it can be seen, since even after getting only the first vaccine shot individuals are partially protected, continuing the vaccine administration rapidly lowers the intensity of the resurgent waves and helps preventing subsequent outbreaks.</p>
                <p id="p0057">Although recent reports on highly infectious variants claim that the efficacy of most vaccines is still about <inline-formula><mml:math id="M177" altimg="si98.svg"><mml:mrow><mml:mn>90</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> in preventing serious illnesses <xref rid="bib0045" ref-type="bibr">[45]</xref>, it is still not clear their performance on halting asymptomatic transmission. In this study, we assumed that the vaccine efficacy on protecting from more infectious variants is the same as for the less infectious ones. Despite this optimistic assumption, the herd immunity threshold is moved to higher values by simply increasing the infection rates.</p>
              </sec>
            </sec>
            <sec id="sec0010">
              <label>5</label>
              <title>Conclusions</title>
              <p id="p0058">Compartmental models are efficient tools to deal with the time evolution of disease outbreaks. They provide us with useful intuition on the impact of non-pharmaceutical intervention in decreasing the number of infectious incidence rates.</p>
              <p id="p0059">In this work, we have augmented the classic SIR model with the ability to accommodate asymptomatic transmission and vaccinated individuals. The SAIVR model is a straightforward deterministic model, which does not take into consideration age, gender or geographic clustering. Despite this, its simplicity and the insights it offers on how key epidemiological variables affect individuals are among its main strengths. Its power also lies in the fact that, as factors such new variants are added to the model, it is easy to adjust its parameters and provide with best fit curves between the data and the model predictions.</p>
              <p id="p0060">Since the inclusion of the Asymptomatic and Vaccinated compartments enlarged the number of parameters and initial conditions of the model, we employed a novel semi-supervised framework to estimate most of them. An unsupervised neural network solves the model’s differential equations over a range of parameters and initial conditions. A supervised approach then incorporates data and determines the optimal initial conditions and modeling parameters that best fit the 27 epidemic curves considered. As expected due to the heterogeneity of the countries sample, the resulting parameters fit are dissimilar although they follow similar trends.</p>
              <p id="p0061">We used these results to shed light on the impact of the vaccination campaign on the future of the pandemic. We pointed out how vaccine hesitancy is one of the most important hurdles of the campaign and further efforts should be done to support people and give them correct information about vaccines. Because of this, vaccinating the critical number of people that have to be immune in order to prevent future outbreaks (i.e. herd immunity), is likely to be out of reach. Widely circulating coronavirus variants are also a threat as they move the herd immunity threshold to higher values. This points out the importance of rapidly reducing the infection rate by any means, such as by imposing restrictive measures in case highly infective new variants appears before the herd immunity threshold is reached. These results manifest the need for continuing the vaccination effort and the drive for achieving high vaccination coverage in order to contain outbreaks generated by new and possibly more infectious variants.</p>
            </sec>
            <sec sec-type="data-availability" id="sec0015">
              <title>Data availability</title>
              <p id="p0062">The code used to perform the fitting is available on GitHub <xref rid="bib0046" ref-type="bibr">[46]</xref>. All study data are either included in the article and supporting information or available in Ref. <xref rid="bib0040" ref-type="bibr">[40]</xref>.</p>
            </sec>
            <sec id="sec0016">
              <title>CRediT author statement</title>
              <p id="p0063">E.K. conceived the proposed model and supervised the study. M.A, and M.M. designed the machine learning procedure and code. M.A. and G.N. performed numerical experiments, collected data and analyzed the results. M.A. wrote the initial draft of the manuscript. All authors critically revised, improved, and reviewed the manuscript in various ways, and gave final approval for publication.</p>
            </sec>
            <sec sec-type="COI-statement">
              <title>Declaration of Competing Interest</title>
              <p id="p0064">Authors declare that they have no conflict of interest.</p>
            </sec>
          </body>
          <back>
            <ref-list id="bib001">
              <title>References</title>
              <ref id="bib0001">
                <label>1</label>
                <element-citation publication-type="journal" id="sbref0001">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kermack</surname>
                      <given-names>W.O.</given-names>
                    </name>
                    <name>
                      <surname>McKendrick</surname>
                      <given-names>A.G.</given-names>
                    </name>
                  </person-group>
                  <article-title>A contribution to the mathematical theory of epidemics</article-title>
                  <source>Proc R Soc Lond A</source>
                  <volume>115</volume>
                  <issue>772</issue>
                  <year>1927</year>
                  <fpage>700</fpage>
                  <lpage>721</lpage>
                </element-citation>
              </ref>
              <ref id="bib0002">
                <label>2</label>
                <element-citation publication-type="journal" id="sbref0002">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kaxiras</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Neofotistos</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Multiple epidemic wave model of the COVID-19 pandemic: modeling study</article-title>
                  <source>J Med Internet Res</source>
                  <volume>22</volume>
                  <issue>7</issue>
                  <year>2020</year>
                  <fpage>e20912</fpage>
                  <pub-id pub-id-type="doi">10.2196/20912</pub-id>
                  <pub-id pub-id-type="pmid">32692690</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0003">
                <label>3</label>
                <element-citation publication-type="journal" id="sbref0003">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Barthélemy</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Barrat</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Pastor-Satorras</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Vespignani</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Dynamical patterns of epidemic outbreaks in complex heterogeneous networks</article-title>
                  <source>J Theor Biol</source>
                  <volume>235</volume>
                  <issue>2</issue>
                  <year>2005</year>
                  <fpage>275</fpage>
                  <lpage>288</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jtbi.2005.01.011</pub-id>
                  <pub-id pub-id-type="pmid">15862595</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0004">
                <label>4</label>
                <element-citation publication-type="journal" id="sbref0004">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ferrari</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Bansal</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Meyers</surname>
                      <given-names>L.A.</given-names>
                    </name>
                    <name>
                      <surname>Bjørnstad</surname>
                      <given-names>O.N.</given-names>
                    </name>
                  </person-group>
                  <article-title>Network frailty and the geometry of herd immunity</article-title>
                  <source>Proc R Soc B</source>
                  <volume>273</volume>
                  <issue>1602</issue>
                  <year>2006</year>
                  <fpage>2743</fpage>
                  <lpage>2748</lpage>
                  <pub-id pub-id-type="doi">10.1098/rspb.2006.3636</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0005">
                <label>5</label>
                <element-citation publication-type="journal" id="sbref0005">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Volz</surname>
                      <given-names>E.</given-names>
                    </name>
                  </person-group>
                  <article-title>SIR dynamics in random networks with heterogeneous connectivity</article-title>
                  <source>J Math Biol</source>
                  <volume>56</volume>
                  <issue>3</issue>
                  <year>2007</year>
                  <fpage>293</fpage>
                  <lpage>310</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00285-007-0116-4</pub-id>
                  <pub-id pub-id-type="pmid">17668212</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0006">
                <label>6</label>
                <element-citation publication-type="journal" id="sbref0006">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tagliazucchi</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Balenzuela</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Travizano</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Mindlin</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Mininni</surname>
                      <given-names>P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Lessons from being challenged by COVID-19</article-title>
                  <source>Chaos Solitons Fractals</source>
                  <volume>137</volume>
                  <year>2020</year>
                  <fpage>109923</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.chaos.2020.109923</pub-id>
                  <pub-id pub-id-type="pmid">32501375</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0007">
                <label>7</label>
                <element-citation publication-type="journal" id="sbref0007">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liu</surname>
                      <given-names>Q.-H.</given-names>
                    </name>
                    <name>
                      <surname>Ajelli</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Aleta</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Merler</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Moreno</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Vespignani</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Measurability of the epidemic reproduction number in data-driven contact networks</article-title>
                  <source>Proc Natl Acad Sci</source>
                  <volume>115</volume>
                  <issue>50</issue>
                  <year>2018</year>
                  <fpage>12680</fpage>
                  <lpage>12685</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1811115115</pub-id>
                  <pub-id pub-id-type="pmid">30463945</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0008">
                <label>8</label>
                <element-citation publication-type="journal" id="sbref0008">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhang</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Verbraeck</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Meng</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Qiu</surname>
                      <given-names>X.</given-names>
                    </name>
                  </person-group>
                  <article-title>Modeling spatial contacts for epidemic prediction in a large-scale artificial city</article-title>
                  <source>J Artif Soc Soc Simul</source>
                  <volume>19</volume>
                  <issue>4</issue>
                  <year>2016</year>
                  <fpage>3</fpage>
                  <pub-id pub-id-type="doi">10.18564/jasss.3148</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0009">
                <label>9</label>
                <element-citation publication-type="journal" id="sbref0009">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Groendyke</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Welch</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Hunter</surname>
                      <given-names>D.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Bayesian inference for contact networks given epidemic data</article-title>
                  <source>Scand J Stat</source>
                  <year>2010</year>
                  <pub-id pub-id-type="doi">10.1111/j.1467-9469.2010.00721.x</pub-id>
                </element-citation>
                <note>
                  <p>no–no</p>
                </note>
              </ref>
              <ref id="bib0010">
                <label>10</label>
                <element-citation publication-type="journal" id="sbref0010">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sanche</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>Y.T.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Romero-Severson</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Hengartner</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Ke</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2</article-title>
                  <source>Emerg Infect Dis</source>
                  <volume>26</volume>
                  <issue>7</issue>
                  <year>2020</year>
                  <fpage>1470</fpage>
                  <lpage>1477</lpage>
                  <pub-id pub-id-type="doi">10.3201/eid2607.200282</pub-id>
                  <pub-id pub-id-type="pmid">32255761</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0011">
                <label>11</label>
                <element-citation publication-type="journal" id="sbref0011">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Guan</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Tong</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Ren</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Leung</surname>
                      <given-names>K.S.</given-names>
                    </name>
                    <name>
                      <surname>Lau</surname>
                      <given-names>E.H.</given-names>
                    </name>
                    <name>
                      <surname>Wong</surname>
                      <given-names>J.Y.</given-names>
                    </name>
                    <name>
                      <surname>Xing</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Xiang</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Tu</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Jin</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Luo</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Shao</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Tao</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Deng</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Shi</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Lam</surname>
                      <given-names>T.T.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>J.T.</given-names>
                    </name>
                    <name>
                      <surname>Gao</surname>
                      <given-names>G.F.</given-names>
                    </name>
                    <name>
                      <surname>Cowling</surname>
                      <given-names>B.J.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Leung</surname>
                      <given-names>G.M.</given-names>
                    </name>
                    <name>
                      <surname>Feng</surname>
                      <given-names>Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia</article-title>
                  <source>New Engl J Med</source>
                  <volume>382</volume>
                  <issue>13</issue>
                  <year>2020</year>
                  <fpage>1199</fpage>
                  <lpage>1207</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa2001316</pub-id>
                  <pub-id pub-id-type="pmid">31995857</pub-id>
                </element-citation>
                <note>
                  <p>PMID: 31995857</p>
                </note>
              </ref>
              <ref id="bib0012">
                <label>12</label>
                <element-citation publication-type="journal" id="sbref0012">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Du</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Cauchemez</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Cowling</surname>
                      <given-names>B.J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Risk for transportation of coronavirus disease from Wuhan to other cities in China</article-title>
                  <source>Emerg Infect Dis</source>
                  <volume>26</volume>
                  <issue>5</issue>
                  <year>2020</year>
                  <fpage>1049</fpage>
                  <lpage>1052</lpage>
                  <pub-id pub-id-type="doi">10.3201/eid2605.200146</pub-id>
                  <pub-id pub-id-type="pmid">32053479</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0013">
                <label>13</label>
                <element-citation publication-type="journal" id="sbref0013">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rothe</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Schunk</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Sothmann</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Bretzel</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Froeschl</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Wallrauch</surname>
                      <given-names>C.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Transmission of 2019-nCoV infection from an asymptomatic contact in Germany</article-title>
                  <source>New Engl J Med</source>
                  <volume>382</volume>
                  <issue>10</issue>
                  <year>2020</year>
                  <fpage>970</fpage>
                  <lpage>971</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMc2001468</pub-id>
                  <pub-id pub-id-type="pmid">32003551</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0014">
                <label>14</label>
                <element-citation publication-type="journal" id="sbref0014">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wynants</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Calster</surname>
                      <given-names>B.V.</given-names>
                    </name>
                    <name>
                      <surname>Collins</surname>
                      <given-names>G.S.</given-names>
                    </name>
                    <name>
                      <surname>Riley</surname>
                      <given-names>R.D.</given-names>
                    </name>
                    <name>
                      <surname>Heinze</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Schuit</surname>
                      <given-names>E.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prediction models for diagnosis and prognosis of COVID-19: systematic review and critical appraisal</article-title>
                  <source>BMJ</source>
                  <year>2020</year>
                  <fpage>m1328</fpage>
                  <pub-id pub-id-type="doi">10.1136/bmj.m1328</pub-id>
                  <pub-id pub-id-type="pmid">32265220</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0015">
                <label>15</label>
                <element-citation publication-type="journal" id="sbref0015">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Koh</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Shah</surname>
                      <given-names>S.U.</given-names>
                    </name>
                    <name>
                      <surname>Chua</surname>
                      <given-names>P.E.Y.</given-names>
                    </name>
                    <name>
                      <surname>Gui</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Pang</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Epidemiological and clinical characteristics of cases during the early phase of COVID-19 pandemic: a systematic review and meta-analysis</article-title>
                  <source>Front Med</source>
                  <volume>7</volume>
                  <year>2020</year>
                  <fpage>295</fpage>
                  <pub-id pub-id-type="doi">10.3389/fmed.2020.00295</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0016">
                <label>16</label>
                <element-citation publication-type="journal" id="sbref0016">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Riccardo</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Ajelli</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Andrianou</surname>
                      <given-names>X.D.</given-names>
                    </name>
                    <name>
                      <surname>Bella</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Del Manso</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Fabiani</surname>
                      <given-names>M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020</article-title>
                  <source>Eurosurveillance</source>
                  <volume>25</volume>
                  <issue>49</issue>
                  <year>2020</year>
                  <fpage>2000790</fpage>
                  <pub-id pub-id-type="doi">10.2807/1560-7917.ES.2020.25.49.2000790</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0017">
                <label>17</label>
                <element-citation publication-type="journal" id="sbref0017">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Khalili</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Karamouzian</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Nasiri</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Javadi</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Mirzazadeh</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Sharifi</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Epidemiological characteristics of COVID-19: a systematic review and meta-analysis</article-title>
                  <source>Epidemiol Infect</source>
                  <volume>148</volume>
                  <year>2020</year>
                  <fpage>e130</fpage>
                  <pub-id pub-id-type="doi">10.1017/S0950268820001430</pub-id>
                  <pub-id pub-id-type="pmid">32594937</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0018">
                <label>18</label>
                <element-citation publication-type="journal" id="sbref0018">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>D.Q.</given-names>
                    </name>
                    <name>
                      <surname>Zou</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Hui</surname>
                      <given-names>W.Z.</given-names>
                    </name>
                    <name>
                      <surname>Rui</surname>
                      <given-names>F.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Epidemiology of COVID-19: a systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes</article-title>
                  <source>J Med Virol</source>
                  <volume>93</volume>
                  <issue>3</issue>
                  <year>2021</year>
                  <fpage>1449</fpage>
                  <lpage>1458</lpage>
                  <pub-id pub-id-type="doi">10.1002/jmv.26424</pub-id>
                  <pub-id pub-id-type="pmid">32790106</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0019">
                <label>19</label>
                <mixed-citation publication-type="other" id="sbref0019">Flamant C., Protopapas P., Sondak D.. Solving differential equations using neural network solution bundles. 2020. <ext-link ext-link-type="uri" xlink:href="http://arxiv.org/abs/2006.14372" id="intrrf0003">arXiv e-prints arXiv:2006.14372</ext-link></mixed-citation>
              </ref>
              <ref id="bib0020">
                <label>20</label>
                <mixed-citation publication-type="other" id="sbref0020">Mattheakis M., Sondak D., Dogra A.S., Protopapas P.. Hamiltonian neural networks for solving differential equations. 2020. <ext-link ext-link-type="uri" xlink:href="http://arxiv.org/abs/2001.11107" id="intrrf0004">arXiv:2001.11107</ext-link></mixed-citation>
              </ref>
              <ref id="bib0021">
                <label>21</label>
                <mixed-citation publication-type="other" id="sbref0021">Paticchio A., Scarlatti T., Mattheakis M., Protopapas P., Brambilla M.. Semi-supervised neural networks solve an inverse problem for modeling COVID-19 spread. 2020. <ext-link ext-link-type="uri" xlink:href="http://arxiv.org/abs/2010.05074" id="intrrf0005">arXiv:2010.05074</ext-link></mixed-citation>
              </ref>
              <ref id="bib0022">
                <label>22</label>
                <element-citation publication-type="journal" id="sbref0022">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Saito</surname>
                      <given-names>M.M.</given-names>
                    </name>
                    <name>
                      <surname>Imoto</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Yamaguchi</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Sato</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Nakada</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Kami</surname>
                      <given-names>M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Extension and verification of the SEIR model on the 2009 influenza a (H1N1) pandemic in Japan</article-title>
                  <source>Math Biosci</source>
                  <volume>246</volume>
                  <issue>1</issue>
                  <year>2013</year>
                  <fpage>47</fpage>
                  <lpage>54</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.mbs.2013.08.009</pub-id>
                  <pub-id pub-id-type="pmid">24012502</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0023">
                <label>23</label>
                <mixed-citation publication-type="other" id="tboref0001">Fang H., Chen J., Hu J.. Modelling the SARS epidemic by a lattice-based Monte–Carlo simulation2005; 10.1109/iembs.2005.1616239</mixed-citation>
              </ref>
              <ref id="bib0024">
                <label>24</label>
                <element-citation publication-type="journal" id="sbref0024">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Smirnova</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>deCamp</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Chowell</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Forecasting epidemics through nonparametric estimation of time-dependent transmission rates using the SEIR model</article-title>
                  <source>Bull Math Biol</source>
                  <volume>81</volume>
                  <issue>11</issue>
                  <year>2017</year>
                  <fpage>4343</fpage>
                  <lpage>4365</lpage>
                  <pub-id pub-id-type="doi">10.1007/s11538-017-0284-3</pub-id>
                  <pub-id pub-id-type="pmid">28466232</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0025">
                <label>25</label>
                <element-citation publication-type="journal" id="sbref0025">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Alanazi</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Kamruzzaman</surname>
                      <given-names>M.M.</given-names>
                    </name>
                    <name>
                      <surname>Alruwaili</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Alshammari</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Alqahtani</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Karime</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Measuring and preventing COVID-19 using the SIR model and machine learning in smart health care</article-title>
                  <source>J Healthc Eng</source>
                  <volume>2020</volume>
                  <year>2020</year>
                  <fpage>1</fpage>
                  <lpage>12</lpage>
                  <pub-id pub-id-type="doi">10.1155/2020/8857346</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0026">
                <label>26</label>
                <mixed-citation publication-type="other" id="sbref0026">Palladino A., Nardelli V., Atzeni L.G., Cantatore N., Cataldo M., Croccolo F., Estrada N., Tombolini A.. Modelling the spread of COVID19 in Italy using a revised version of the SIR model. 2020. <ext-link ext-link-type="uri" xlink:href="http://arxiv.org/abs/2005.08724" id="intrrf0006">arXiv:2005.08724</ext-link></mixed-citation>
              </ref>
              <ref id="bib0027">
                <label>27</label>
                <element-citation publication-type="journal" id="sbref0027">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cooper</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Mondal</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Antonopoulos</surname>
                      <given-names>C.G.</given-names>
                    </name>
                  </person-group>
                  <article-title>A SIR model assumption for the spread of COVID-19 in different communities</article-title>
                  <source>Chaos Solitons Fractals</source>
                  <volume>139</volume>
                  <year>2020</year>
                  <fpage>110057</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.chaos.2020.110057</pub-id>
                  <pub-id pub-id-type="pmid">32834610</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0028">
                <label>28</label>
                <element-citation publication-type="journal" id="sbref0028">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Buitrago-Garcia</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Egli-Gany</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Counotte</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Hossmann</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Imeri</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Ipekci</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis</article-title>
                  <source>PLoS Med</source>
                  <volume>17</volume>
                  <issue>9</issue>
                  <year>2020</year>
                  <fpage>1</fpage>
                  <lpage>25</lpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pmed.1003346</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0029">
                <label>29</label>
                <mixed-citation publication-type="other" id="tboref0002">Byambasuren O., Cardona M., Bell K., Clark J., McLaws M.-L., Glasziou P.. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. medRxiv202010.1101/2020.05.10.20097543</mixed-citation>
              </ref>
              <ref id="bib0030">
                <label>30</label>
                <element-citation publication-type="journal" id="sbref0030">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hossain</surname>
                      <given-names>M.K.</given-names>
                    </name>
                    <name>
                      <surname>Hassanzadeganroudsari</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Apostolopoulos</surname>
                      <given-names>V.</given-names>
                    </name>
                  </person-group>
                  <article-title>The emergence of new strains of SARS-CoV-2. what does it mean for COVID-19 vaccines?</article-title>
                  <source>Expert Rev Vaccines</source>
                  <volume>0</volume>
                  <issue>0</issue>
                  <year>2021</year>
                  <fpage>1</fpage>
                  <lpage>4</lpage>
                  <pub-id pub-id-type="doi">10.1080/14760584.2021.1915140</pub-id>
                </element-citation>
                <note>
                  <p>PMID: 33896316</p>
                </note>
              </ref>
              <ref id="bib0031">
                <label>31</label>
                <mixed-citation publication-type="other" id="sbref0031">Wang R., Maddix D., Faloutsos C., Wang Y., Yu R.. Bridging physics-based and data-driven modeling for learning dynamical systems. 2021. <ext-link ext-link-type="uri" xlink:href="http://arxiv.org/abs/2011.10616" id="intrrf0007">arXiv:2011.10616</ext-link></mixed-citation>
              </ref>
              <ref id="bib0032">
                <label>32</label>
                <element-citation publication-type="journal" id="sbref0032">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yang</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Zeng</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Wong</surname>
                      <given-names>S.-S.</given-names>
                    </name>
                    <name>
                      <surname>Liang</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Zanin</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Cao</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Gao</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Mai</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Liang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Ye</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Guan</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Luo</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Xie</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Zhong</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>He</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions</article-title>
                  <source>J Thorac Dis</source>
                  <volume>12</volume>
                  <issue>3</issue>
                  <year>2020</year>
                  <fpage>165</fpage>
                  <lpage>174</lpage>
                  <pub-id pub-id-type="pmid">32274081</pub-id>
                </element-citation>
                <note>
                  <p>
                    <ext-link ext-link-type="uri" xlink:href="https://jtd.amegroups.com/article/view/36385" id="intrrf0008">https://jtd.amegroups.com/article/view/36385</ext-link>
                  </p>
                </note>
              </ref>
              <ref id="bib0033">
                <label>33</label>
                <mixed-citation publication-type="other" id="tboref0003">Zou D., Wang L., Xu P., Chen J., Zhang W., Gu Q.. Epidemic model guided machine learning for COVID-19forecasts in the United States. medRxiv2020;. 10.1101/2020.05.24.20111989</mixed-citation>
              </ref>
              <ref id="bib0034">
                <label>34</label>
                <mixed-citation publication-type="other" id="sbref0034">Ayed I., Bézenac E.D., Pajot A., Gallinari P.. Learning partially observed PDE dynamics with neural networks. 2019. <ext-link ext-link-type="uri" xlink:href="https://openreview.net/forum?id=HyefgnCqFm" id="intrrf0009">https://openreview.net/forum?id=HyefgnCqFm</ext-link>.</mixed-citation>
              </ref>
              <ref id="bib0035">
                <label>35</label>
                <element-citation publication-type="book" id="sbref0035">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>R.T.Q.</given-names>
                    </name>
                    <name>
                      <surname>Rubanova</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Bettencourt</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Duvenaud</surname>
                      <given-names>D.K.</given-names>
                    </name>
                  </person-group>
                  <part-title>Neural ordinary differential equations</part-title>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Bengio</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Wallach</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Larochelle</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Grauman</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Cesa-Bianchi</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Garnett</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <source>Advances in neural information processing systems</source>
                  <volume>vol. 31</volume>
                  <year>2018</year>
                  <publisher-name>Curran Associates, Inc.</publisher-name>
                </element-citation>
                <note>
                  <p>
                    <ext-link ext-link-type="uri" xlink:href="https://proceedings.neurips.cc/paper/2018/file/69386f6bb1dfed68692a24c8686939b9-Paper.pdf" id="intrrf0010">https://proceedings.neurips.cc/paper/2018/file/69386f6bb1dfed68692a24c8686939b9-Paper.pdf</ext-link>
                  </p>
                </note>
              </ref>
              <ref id="bib0036">
                <label>36</label>
                <mixed-citation publication-type="other" id="tboref0004">Paszke A., Gross S., Chintala S., Chanan G., Yang E., DeVito Z., Lin Z., Desmaison A., Antiga L., Lerer A.. Automatic differentiation in Pytorch2017.</mixed-citation>
              </ref>
              <ref id="bib0037">
                <label>37</label>
                <element-citation publication-type="journal" id="sbref0037">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Polack</surname>
                      <given-names>F.P.</given-names>
                    </name>
                    <name>
                      <surname>Thomas</surname>
                      <given-names>S.J.</given-names>
                    </name>
                    <name>
                      <surname>Kitchin</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Absalon</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Gurtman</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Lockhart</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Perez</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Pérez Marc</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Moreira</surname>
                      <given-names>E.D.</given-names>
                    </name>
                    <name>
                      <surname>Zerbini</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Bailey</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Swanson</surname>
                      <given-names>K.A.</given-names>
                    </name>
                    <name>
                      <surname>Roychoudhury</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Koury</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Kalina</surname>
                      <given-names>W.V.</given-names>
                    </name>
                    <name>
                      <surname>Cooper</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Frenck</surname>
                      <given-names>R.W.</given-names>
                    </name>
                    <name>
                      <surname>Hammitt</surname>
                      <given-names>L.L.</given-names>
                    </name>
                    <name>
                      <surname>Türeci</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Nell</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Schaefer</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Ünal</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Tresnan</surname>
                      <given-names>D.B.</given-names>
                    </name>
                    <name>
                      <surname>Mather</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Dormitzer</surname>
                      <given-names>P.R.</given-names>
                    </name>
                    <name>
                      <surname>Sahin</surname>
                      <given-names>U.</given-names>
                    </name>
                    <name>
                      <surname>Jansen</surname>
                      <given-names>K.U.</given-names>
                    </name>
                    <name>
                      <surname>Gruber</surname>
                      <given-names>W.C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine</article-title>
                  <source>New Engl J Med</source>
                  <volume>383</volume>
                  <issue>27</issue>
                  <year>2020</year>
                  <fpage>2603</fpage>
                  <lpage>2615</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa2034577</pub-id>
                  <pub-id pub-id-type="pmid">33301246</pub-id>
                </element-citation>
                <note>
                  <p>PMID: 33301246</p>
                </note>
              </ref>
              <ref id="bib0038">
                <label>38</label>
                <element-citation publication-type="journal" id="sbref0038">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baden</surname>
                      <given-names>L.R.</given-names>
                    </name>
                    <name>
                      <surname>El Sahly</surname>
                      <given-names>H.M.</given-names>
                    </name>
                    <name>
                      <surname>Essink</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Kotloff</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Frey</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Novak</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Diemert</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Spector</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Rouphael</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Creech</surname>
                      <given-names>C.B.</given-names>
                    </name>
                    <name>
                      <surname>McGettigan</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Khetan</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Segall</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Solis</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Brosz</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Fierro</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Schwartz</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Neuzil</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Corey</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Gilbert</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Janes</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Follmann</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Marovich</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Mascola</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Polakowski</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Ledgerwood</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Graham</surname>
                      <given-names>B.S.</given-names>
                    </name>
                    <name>
                      <surname>Bennett</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Pajon</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Knightly</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Leav</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Deng</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Ivarsson</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Zaks</surname>
                      <given-names>T.</given-names>
                    </name>
                  </person-group>
                  <article-title>Efficacy and safety of the mRNA-1273 SARS-CoV-2vaccine</article-title>
                  <source>New Engl J Med</source>
                  <volume>384</volume>
                  <issue>5</issue>
                  <year>2021</year>
                  <fpage>403</fpage>
                  <lpage>416</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa2035389</pub-id>
                  <pub-id pub-id-type="pmid">33378609</pub-id>
                </element-citation>
                <note>
                  <p>PMID: 33378609</p>
                </note>
              </ref>
              <ref id="bib0039">
                <label>39</label>
                <element-citation publication-type="journal" id="sbref0039">
                  <person-group person-group-type="author">
                    <name>
                      <surname>George</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Tyagi</surname>
                      <given-names>N.K.</given-names>
                    </name>
                    <name>
                      <surname>Prasad</surname>
                      <given-names>J.B.</given-names>
                    </name>
                  </person-group>
                  <article-title>COVID-19 pandemic and its average recovery time in Indian states</article-title>
                  <source>Clin Epidemiol Glob Health</source>
                  <volume>11</volume>
                  <year>2021</year>
                  <fpage>100740</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.cegh.2021.100740</pub-id>
                  <pub-id pub-id-type="pmid">33875974</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0040">
                <label>40</label>
                <mixed-citation publication-type="other" id="sbref0040">Our world in data github repository: 2021;<ext-link ext-link-type="uri" xlink:href="https://github.com/owid/covid-19-data" id="intrrf0011">https://github.com/owid/covid-19-data</ext-link>.</mixed-citation>
              </ref>
              <ref id="bib0041">
                <label>41</label>
                <element-citation publication-type="journal" id="sbref0041">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Omer</surname>
                      <given-names>S.B.</given-names>
                    </name>
                    <name>
                      <surname>Yildirim</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Forman</surname>
                      <given-names>H.P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Herd immunity and implications for SARS-CoV-2 control</article-title>
                  <source>JAMA</source>
                  <volume>324</volume>
                  <issue>20</issue>
                  <year>2020</year>
                  <fpage>2095</fpage>
                  <lpage>2096</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2020.20892</pub-id>
                  <pub-id pub-id-type="pmid">33074293</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0042">
                <label>42</label>
                <element-citation publication-type="journal" id="sbref0042">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chowdhury</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Roychowdhury</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Chaudhuri</surname>
                      <given-names>I.</given-names>
                    </name>
                  </person-group>
                  <article-title>Universality and herd immunity threshold: revisiting the sir model for COVID-19</article-title>
                  <source>Int J Mod Phys C</source>
                  <volume>0</volume>
                  <issue>0</issue>
                  <year>2020</year>
                  <fpage>2150128</fpage>
                  <pub-id pub-id-type="doi">10.1142/S012918312150128X</pub-id>
                </element-citation>
              </ref>
              <ref id="bib0043">
                <label>43</label>
                <mixed-citation publication-type="other" id="tboref0005">Aguas R., Corder R.M., King J.G., Gonçalves G., Ferreira M.U., Gomes M.G.M.. Herd immunity thresholds for SARS-CoV-2 estimated from unfolding epidemics. medRxiv2020. 10.1101/2020.07.23.20160762</mixed-citation>
              </ref>
              <ref id="bib0044">
                <label>44</label>
                <mixed-citation publication-type="other" id="tboref0006">Arora P., Kempf A., Nehlmeier I., Sidarovich A., Krüger N., Graichen L., Moldenhauer A.-S., Winkler M.S., Schulz S., Jäck H.-M., Stankov M.V., Behrens G.M.N., Pöhlmann S., Hoffmann M.. Increased lung cell entry of B.1.617.2 and evasion of antibodies induced by infection and BNT162b2 vaccination. bioRxiv202110.1101/2021.06.23.449568</mixed-citation>
              </ref>
              <ref id="bib0045">
                <label>45</label>
                <mixed-citation publication-type="other" id="tboref0007">Bernal J.L., Andrews N., Gower C., Gallagher E., Simmons R., Thelwall S., Stowe J., Tessier E., Groves N., Dabrera G., Myers R., Campbell C., Amirthalingam G., Edmunds M., Zambon M., Brown K., Hopkins S., Chand M., Ramsay M.. Effectiveness of COVID-19 vaccines against the B.1.617.2 variant. medRxiv2021;. 10.1101/2021.05.22.21257658</mixed-citation>
              </ref>
              <ref id="bib0046">
                <label>46</label>
                <mixed-citation publication-type="other" id="othref0004">MLCD machine learning COVID dynamics2021, <ext-link ext-link-type="uri" xlink:href="https://github.com/mattangeli/mlcd-machine-learning-covid-dynamics" id="intrrf0012">https://github.com/mattangeli/mlcd-machine-learning-covid-dynamics</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://github.com/mattangeli/MLCD-Machine-Learning-Covid-Dynamics" id="intrrf0013">https://github.com/mattangeli/MLCD-Machine-Learning-Covid-Dynamics</ext-link>.</mixed-citation>
              </ref>
              <ref id="bib0047">
                <label>47</label>
                <mixed-citation publication-type="other" id="othref0005">Kingma D.P., Ba J.. Adam: a method for stochastic optimization. 2017. <ext-link ext-link-type="uri" xlink:href="http://arxiv.org/abs/1412.6980" id="intrrf0014">arXiv:1412.6980</ext-link></mixed-citation>
              </ref>
            </ref-list>
            <sec id="sec0011">
              <label>Appendix A</label>
              <title>Computational methods</title>
              <p id="p0065">We implemented a fully connected feed forward neural network that consists of six hidden layers with 48 neurons per layer and Sigmoid activation functions. The code is written in PyTorch <xref rid="bib0036" ref-type="bibr">[36]</xref> and published on GitHub <xref rid="bib0046" ref-type="bibr">[46]</xref>. In the following we list the technical details of the learning procedure described in <xref rid="sec0003" ref-type="sec">Section 3</xref>:</p>
              <sec id="sec0012">
                <label>A1</label>
                <title>Unsupervised learning</title>
                <p id="p0066">The network parameters (weights and biases) are updated with an adaptive learning rate using the Adam algorithm <xref rid="bib0047" ref-type="bibr">[47]</xref> until the loss <inline-formula><mml:math id="M178" altimg="si7.svg"><mml:mi mathvariant="script">L</mml:mi></mml:math></inline-formula> of <xref rid="eq0013" ref-type="disp-formula">Eq. (5)</xref> becomes smaller than <inline-formula><mml:math id="M179" altimg="si99.svg"><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>−</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula>. The learning rate ranged from 0.001 to <inline-formula><mml:math id="M180" altimg="si100.svg"><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>−</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula>. The (initial) infectious and asymptomatic populations involved in realistic situations are a small fraction of the total population. The ODEs in Eq. (2) are highly non-linear and extremely sensitive on initial conditions. Subsequently, training the unsupervised network for the initial conditions given in <xref rid="tbl0001" ref-type="table">Table 1</xref> is very challenging. To cope with this, we started by training the network with a different choice of initial condition bundles taken in ‘safer’ intervals (<inline-formula><mml:math id="M181" altimg="si101.svg"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mn>10</mml:mn><mml:mo>%</mml:mo><mml:mo>,</mml:mo><mml:mn>30</mml:mn><mml:mo>%</mml:mo><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) where the network was able to quickly learn the solutions with high-accuracy. Then, we gradually decreased <inline-formula><mml:math id="M182" altimg="si24.svg"><mml:msub><mml:mi>I</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="M183" altimg="si25.svg"><mml:msub><mml:mi>A</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula> until they meet the values in <xref rid="tbl0001" ref-type="table">Table 1</xref>, while we keep training the network using the previously trained weights and biases. After performing this annealing procedure, the network was able to learn the solutions of the family of ODE defined by <xref rid="tbl0001" ref-type="table">Table 1</xref>.</p>
              </sec>
              <sec id="sec0013">
                <label>A2</label>
                <title>Supervised learning and fitting procedure</title>
                <p id="p0067">The SAIVR parameters and initial conditions are updated with a stochastic gradient descent algorithm. Whenever the infection wave started before the vaccination campaign, we divided the time series in two parts: before (<inline-formula><mml:math id="M184" altimg="si102.svg"><mml:mrow><mml:mi>δ</mml:mi><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula>) and after (<inline-formula><mml:math id="M185" altimg="si103.svg"><mml:mrow><mml:mi>δ</mml:mi><mml:mo linebreak="goodbreak">&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula>) the vaccination campaign began. The first shot vaccination rate <inline-formula><mml:math id="M186" altimg="si13.svg"><mml:mi>δ</mml:mi></mml:math></inline-formula> can abruptly change in time based on logistics, social or political reasons. Therefore, instead of fitting <inline-formula><mml:math id="M187" altimg="si13.svg"><mml:mi>δ</mml:mi></mml:math></inline-formula> as we did with the other parameters in the bundles we estimated it using real data, with the aim of reproducing the average number of vaccinated people. The Vaccinated compartment counts those individuals who have received the first shot but have not been fully immunized yet. We defined the average number of people in the vaccinated compartment <inline-formula><mml:math id="M188" altimg="si104.svg"><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo>˜</mml:mo></mml:mover></mml:math></inline-formula> in a given time interval as <inline-formula><mml:math id="M189" altimg="si105.svg"><mml:mrow><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo>˜</mml:mo></mml:mover><mml:mo linebreak="goodbreak">=</mml:mo><mml:msubsup><mml:mo>∫</mml:mo><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:msubsup><mml:mi>V</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mi>ϵ</mml:mi><mml:mspace width="0.33em"/><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></inline-formula>, where <inline-formula><mml:math id="M190" altimg="si37.svg"><mml:mi>ϵ</mml:mi></mml:math></inline-formula> is the <inline-formula><mml:math id="M191" altimg="si84.svg"><mml:mrow><mml:mi>V</mml:mi><mml:mo>→</mml:mo><mml:mi>R</mml:mi></mml:mrow></mml:math></inline-formula> rate. Then, we computed with a similar procedure <inline-formula><mml:math id="M192" altimg="si106.svg"><mml:msub><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo>˜</mml:mo></mml:mover><mml:mrow><mml:mi>D</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> using data relative to a given country and where <inline-formula><mml:math id="M193" altimg="si107.svg"><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>D</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> is the difference between the total number of people who got at least one shot and those fully vaccinated. <inline-formula><mml:math id="M194" altimg="si13.svg"><mml:mi>δ</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="M195" altimg="si26.svg"><mml:msub><mml:mi>V</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula> were selected to match <inline-formula><mml:math id="M196" altimg="si104.svg"><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo>˜</mml:mo></mml:mover></mml:math></inline-formula> with <inline-formula><mml:math id="M197" altimg="si106.svg"><mml:msub><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo>˜</mml:mo></mml:mover><mml:mrow><mml:mi>D</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>.</p>
                <p id="p0068">Although <inline-formula><mml:math id="M198" altimg="si24.svg"><mml:msub><mml:mi>I</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula> was provided in the data, we did not fix it during the fitting. We have empirically observed that the network generalizes better in this case.</p>
                <p id="p0069">The fitting procedure was performed 20 times for any given data-set in order to select the parameters and initial conditions that fit the ground-truth data with the lowest loss of <xref rid="eq0014" ref-type="disp-formula">Eq. (6)</xref>.</p>
              </sec>
            </sec>
            <sec id="sec0018" sec-type="supplementary-material">
              <title>Supplementary material</title>
              <p id="p0070">Supplementary material associated with this article can be found, in the online version, at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.chaos.2021.111621" id="intrrf0001">10.1016/j.chaos.2021.111621</ext-link>
</p>
            </sec>
            <sec id="sec0014" sec-type="supplementary-material">
              <label>Appendix B</label>
              <title>Supplementary materials</title>
              <p id="p0071">
                <supplementary-material content-type="local-data" id="ecom0001">
                  <caption>
                    <title>Supplementary Data S1</title>
                    <p>Supplementary Raw Research Data. This is open data under the CC BY license <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" id="intrrf0002">http://creativecommons.org/licenses/by/4.0/</ext-link></p>
                  </caption>
                  <media xlink:href="mmc1.pdf">
                    <alt-text>Supplementary Data S1</alt-text>
                  </media>
                </supplementary-material>
              </p>
            </sec>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
